Health & Fitness

JACC Specialty Journals

by American College of Cardiology

Share this ranking Claiming needs an RSS feed. Contact us.

Listen on Apple Podcasts

Chart positions today · India

Not on the India charts we track today.

If you like JACC Specialty Journals, try…

JACC Author Interviews

From American College of Cardiology

JACC Global

From American College of Cardiology

Journal of Clinical Oncology (JCO) Podcast

Latest episodes

XGBoost Model with CMR Features for Prognostic Assessment in Patients With ST‑Segment Elevation Myocardial Infarction | JACC: Asia

October 20, 2026 · 5 min

Commentary by Dr. Yoriyasu Suzuki.
Design and Rationale of GPS-CAD: Global Pretest Probability Study of Coronary Artery Disease | JACC: Asia

October 20, 2026 · 4 min

Commentary by Dr. Junjie Yang.
Prediction of Paroxysmal Atrial Fibrillation with Incorporating Genomic Information Into AI-Based ECG Analysis | JACC: Asia

October 20, 2026 · 3 min

Commentary by Dr. Qinkai Yu.
October 2026 Summary | JACC: CardioOncology

October 20, 2026 · 2 min

Editor-in-Chief Dr. Bonnie Ky introduces the October 2026 issue of JACC: CardioOncology, featuring Part 1 of a special focus on immunology and cardio-oncology. This issue brings together state-of-the-art reviews, primers, original…
Fibrotic Rewiring of CD8+ T-cells by Doxorubicin Drives Pathological Remodeling of Cardiac Extracellular Matrix | JACC: CardioOncology

October 20, 2026 · 3 min

Dr. Caitlin O'Meara discusses a JACC: CardioOncology study showing that doxorubicin reprograms CD8+ T cells into matrix-remodeling T cells (mxT-cells) that produce lysyl oxidase (LOX) and stiffen the cardiac extracellular matrix through…

Show 7 more episodesShow fewer episodes

High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors | JACC: CardioOncology

October 20, 2026 · 5 min

Dr. David Austin discusses a JACC: CardioOncology study showing that high-sensitivity cardiac troponin T was elevated in 37.9% of patients starting immune checkpoint inhibitor (ICI) therapy, compared with only 1.8% for high-sensitivity…
Inflammatory Cell Profiles in Early- and Late-Manifestation Immune Checkpoint Inhibitor Myocarditis | JACC: CardioOncology

October 20, 2026 · 4 min

Dr. Cristina Gil-Cruz discusses a JACC: CardioOncology study comparing early- and late-manifestation immune checkpoint inhibitor (ICI) myocarditis, where endomyocardial biopsies showed greater T-cell and macrophage infiltration in early…
Impact of Device Position and Aortic Valve Prolapse on Outcomes After Transcatheter VSD Closure | JACC: Asia

October 7, 2026 · 4 min

Commentary by Dr. Timothy Un.
Prognostic Impact of Residual Thrombus After Aspiration Thrombectomy in ST-Elevation Myocardial Infarction | JACC: Asia

October 7, 2026 · 4 min

Commentary by Dr. Ziyad Ghazzal.
Sex-Specific Lipid, Apolipoprotein B, and Lipoprotein(a) Responses to Berberine Based on 2 Randomized Placebo-Controlled Trials | JACC: Asia

October 7, 2026 · 3 min

Commentary by Dr. Yihang Fan.
Lifestyle and Metabolic Health, Low-Grade to Clinically Elevated Albuminuria, and Cardiovascular-Renal Diseases | JACC: Asia

October 7, 2026 · 4 min

Commentary by Dr. Hongmei Yan.
Efficacy and Safety of Quarterly Dosing SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia | JACC: Asia

October 7, 2026 · 5 min

Commentary by Dr. Xiaojie Xie.

Full episode archive on Apple Podcasts →

About the show

In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.